A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone

Clinical trial NCT01288573 · COMPLETED

Trial details

NCT number: NCT01288573
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ewing's Sarcoma/Soft Tissue Sarcoma Neuroblastoma Brain Tumors

Start date: 2014-03-03
Primary completion: 2017-05-09
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.